MIR3117

Across TCGA pan-cancer cohorts, MIR3117 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR3117 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR3117 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR3117 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

BLCA, COAD, and THYM are the cancer types where MIR3117 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.854	0.628	.003	111	view →
COAD	OS	Tertile	II,III,IV	0.661	0.870	.001	99	view →
THYM	OS	Tertile	All	0.619	0.978	<.001	75	view →
STAD	DFS	Quartile	II,III,IV	0.369	0.574	.002	46	view →
CESC	DFS	Tertile	III,IV	0.292	0.670	.013	36	view →
ACC	DFS	Tertile	III,IV	0.010	0.364	<.001	27	view →
KIRC	DFS	Quartile	IV	0.289	0.655	.002	24	view →
LIHC	DFS	Tertile	II,III,IV	0.161	0.430	.024	21	view →
LUSC	DFS	Tertile	III,IV	1.000	0.344	.011	19	view →
DLBC	DFS	Tertile	All	0.022	0.809	<.001	18	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
KIRP	OS	Tertile	All	1.000	0.836	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR3117–BLCA (OS)

Open the BLCA breakdown →